A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
- PMID: 17408237
- PMCID: PMC2751305
- DOI: 10.1208/aapsj0901007
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
Abstract
An overview is provided of the present population analysis methods and an assessment of which software packages are most appropriate for various PK/PD modeling problems. Four PK/PD example problems were solved using the programs NONMEM VI beta version, PDx-MCPEM, S-ADAPT, MONOLIX, and WinBUGS, informally assessed for reasonable accuracy and stability in analyzing these problems. Also, for each program we describe their general interface, ease of use, and abilities. We conclude with discussing which algorithms and software are most suitable for which types of PK/PD problems. NONMEM FO method is accurate and fast with 2-compartment models, if intra-individual and interindividual variances are small. The NONMEM FOCE method is slower than FO, but gives accurate population values regardless of size of intra- and interindividual errors. However, if data are very sparse, the NONMEM FOCE method can lead to inaccurate values, while the Laplace method can provide more accurate results. The exact EM methods (performed using S-ADAPT, PDx-MCPEM, and MONOLIX) have greater stability in analyzing complex PK/PD models, and can provide accurate results with sparse or rich data. MCPEM methods perform more slowly than NONMEM FOCE for simple models, but perform more quickly and stably than NONMEM FOCE for complex models. WinBUGS provides accurate assessments of the population parameters, standard errors and 95% confidence intervals for all examples. Like the MCPEM methods, WinBUGS's efficiency increases relative to NONMEM when solving the complex PK/PD models.
Similar articles
-
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003. Clin Pharmacokinet. 2006. PMID: 16584284
-
Performance of different population pharmacokinetic algorithms.Ther Drug Monit. 2011 Oct;33(5):583-91. doi: 10.1097/FTD.0b013e318232bc61. Ther Drug Monit. 2011. PMID: 21912327
-
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Br J Clin Pharmacol. 2007 Nov;64(5):603-12. doi: 10.1111/j.1365-2125.2007.02975.x. Epub 2007 Aug 15. Br J Clin Pharmacol. 2007. PMID: 17711538 Free PMC article. Review.
-
Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):359-70. doi: 10.1007/s10928-016-9476-y. Epub 2016 May 23. J Pharmacokinet Pharmacodyn. 2016. PMID: 27215925
-
A Critique of Computer Simulation Software's Used in Pharmacokinetics and Pharmacodynamics Analysis.Curr Clin Pharmacol. 2018;13(4):216-235. doi: 10.2174/1574884713666181025144845. Curr Clin Pharmacol. 2018. PMID: 30360723 Review.
Cited by
-
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e00952-16. doi: 10.1128/AAC.00952-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27795367 Free PMC article.
-
Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01011-16. doi: 10.1128/AAC.01011-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27821448 Free PMC article.
-
Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data.Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):729-736. doi: 10.1007/s13318-018-0484-8. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29785609
-
Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01268-17. doi: 10.1128/AAC.01268-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28993331 Free PMC article.
-
Non-linear mixed-effects modelling and population-based model selection for 131I kinetics in benign thyroid disease.EJNMMI Phys. 2025 Apr 8;12(1):37. doi: 10.1186/s40658-025-00735-6. EJNMMI Phys. 2025. PMID: 40198532 Free PMC article.
References
-
- mandema JW. Population pharmacokinetics and pharmacodynamics. In: Welling PG, Tse FLS, editors. Pharmacokinetics. 2nd ed. New York, NY: Marcel Dekker, Inc.; 1995. pp. 411–450.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources